These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 7133228)
1. Ceruloplasmin in Hodgkin's disease. Koprivová H; Dienstbier Z; Sámal M; Foltýnová V Neoplasma; 1982; 29(3):333-40. PubMed ID: 7133228 [TBL] [Abstract][Full Text] [Related]
2. Value of laboratory indicators in Hodgkin's disease: preliminary results. Ray GR; Wolf PH; Kaplan HS Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591 [No Abstract] [Full Text] [Related]
3. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels. Sirsat AV; Raste AS; Talavdekar RV; Advani SH Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729 [No Abstract] [Full Text] [Related]
4. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy. Margerison AC; Mann JR Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543 [TBL] [Abstract][Full Text] [Related]
5. [Correlation between serum values of copper, ceruloplasmin, SMAO, SDAO, in health- subjects, in pregnant women and in some pathological conditions (author's transl)]. Bombardieri G; Rossi L; Bevilacqua E; Fabiani S; Tettamanti P Quad Sclavo Diagn; 1976 Jun; 12(2):131-47. PubMed ID: 828961 [TBL] [Abstract][Full Text] [Related]
6. [Significance of some humoral and cytological indices in active stages of Hodgkin's disease]. Barbui T; Dini E; Chisesi T; Corà R; Franchi F; Cazzavillan M; Battista R Haematologica; 1972; 57(9):488-92. PubMed ID: 4125445 [No Abstract] [Full Text] [Related]
7. [Diagnostic value of determination of ceruloplasmin activity and haptoglobin level in patients with lymphogranulomatosis]. Vasygova NF; Lorie IuI Vestn Akad Med Nauk SSSR; 1974; (12):20-4. PubMed ID: 4446705 [No Abstract] [Full Text] [Related]
8. Value of an enzymatic assay for the determination of serum ceruloplasmin. Macintyre G; Gutfreund KS; Martin WR; Camicioli R; Cox DW J Lab Clin Med; 2004 Dec; 144(6):294-301. PubMed ID: 15614251 [TBL] [Abstract][Full Text] [Related]
9. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma. Bien E; Balcerska A Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554 [TBL] [Abstract][Full Text] [Related]
10. Phagocytic activity of peripheral blood leukocytes in patients with Hodgkin's disease. Sámal M; Kirschnerová Z; Jirkovský J; Foltýnová V; Dienstbier Z Czech Med; 1981; 4(4):224-30. PubMed ID: 7035102 [TBL] [Abstract][Full Text] [Related]
11. Serum ceruloplasmin levels in patients of leukaemias, Hodgkin's and non-Hodgkin's lymphomas. Aggarwal AK; Sanwalka AB; Vadehra PL; Prabhakar BR Indian J Pathol Microbiol; 1984 Oct; 27(4):347-52. PubMed ID: 6534868 [No Abstract] [Full Text] [Related]
12. Nucleoli in lymphocytes of the peripheral blood in Hodgkin's disease: I. Changes in the course of the disease. Dientsbier Z; Foltýnová V; Rezný Z; Vĕtrovcová E Czech Med; 1978; 1(3):142-52. PubMed ID: 699718 [TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor. Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922 [TBL] [Abstract][Full Text] [Related]
14. [Blood copper and ceruloplasmin levels in hemolymphopathies. I. Malignant lymphoma]. Tura S; Bernardi L; Baccarani M; Sanguinetti F; Branzi A G Clin Med; 1968 Nov; 49(11):1090-104. PubMed ID: 5757473 [No Abstract] [Full Text] [Related]
15. [Serum ferritin and other biological parameters as indicators of tumor activity in Hodgkin's disease]. Hermosa V; Mazo E; Baró J; Castillo E; Cordovilla JJ; Carril J; Zubizarreta A Sangre (Barc); 1985; 30(2):154-8. PubMed ID: 2409612 [No Abstract] [Full Text] [Related]
16. [Behavior and prognostic significance of serum ceruloplasmin in relation to the histopathological aspect of Hodgkin's disease]. Pisi E; Di Feliciantonio R; Figus E; Ferri S Minerva Med; 1968 Feb; 59(17):944-52. PubMed ID: 5652623 [No Abstract] [Full Text] [Related]
17. Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemias. Bien E; Balcerska A; Adamkiewicz-Drozynska E; Rapala M; Krawczyk M; Stepinski J Clin Biochem; 2009 Jul; 42(10-11):1144-57. PubMed ID: 19376105 [TBL] [Abstract][Full Text] [Related]
18. [The onset of psychiatric disorders and Wilson's disease]. Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784 [TBL] [Abstract][Full Text] [Related]
19. Serum copper compared to erythrocyte sedimentation rate as indicator of disease activity in Hodgkin's disease. Asbjörnsen G Scand J Haematol; 1979 Mar; 22(3):193-6. PubMed ID: 451449 [TBL] [Abstract][Full Text] [Related]
20. [Blood ceruloplasmin levels in acute lymphoblastic leukemia and Hodgkin's disease in childhood]. Masi M; Vecchi V; Vivarelli F; Paolucci P Minerva Pediatr; 1975 Jun; 27(22):1223-8. PubMed ID: 1056499 [No Abstract] [Full Text] [Related] [Next] [New Search]